Daily non-political popular news in brief.

How will responders respond?

05-16-2007 · EurekAlert!

Hospital staffing is key in disaster planning, especially within the emergency department. Yet, mandatory assignment does not guarantee attendance. This study tested the hypothesis that healthcare workers perceptions and expectations about their role in disaster response influence their willingness and ability to work during disasters.

Keywords: responders, respond, responder

« Previous | Next »

Similar news on "How will responders respond?":

Radar opens new window into the ice for Antarctic scientists
10-16-2006 · EurekAlert!
Scientists are getting their first glimpse into the inner secrets of an ice shelf, thanks to the innovative application of a new radar technique developed by British Antarctic Survey (BAS). Getting a clearer view of how ice behaves is important because it will help scientists predict more accurately how the ice sheet will respond to future climate change. The results are published this week in the Journal of Glaciology.
Similar news · Read more »
Soil nutrition affects carbon sequestration in forests
12-13-2006 · EurekAlert!
On December 11, USDA Forest Service (FS) scientists from the FS Southern Research Station (SRS) unit in Research Triangle Park, NC, along with colleagues from Duke University, published two papers in The Proceedings of the National Academy of Science (PNAS) that provide a more precise understanding of how forests respond to increasing atmospheric concentrations of carbon dioxide (CO2), the major greenhouse gas driving climate change.
Similar news · Read more »
Making daughters different -- How immune cells take divergent paths when fighting infections
03-01-2007 · EurekAlert!
How do immune cells decide to respond to invading microbes by either fighting to the death or becoming the body's memory for future infections? Researchers at the University of Pennsylvania School of Medicine have discovered that immune cells can differ in their inheritance of molecules that regulate cell fate, and therefore what role they play in fighting infection.
Similar news · Read more »
Why cisplatin kills breast cancer cells when other drugs fail
04-19-2007 · EurekAlert!
The cancerous cells of some individuals with breast cancer lack expression of two cell surface proteins, the estrogen and progesterone receptors, and do not express increased amounts of HER2. Individuals with such breast cancer (known as triple-negative breast cancer) do not respond to treatment with commonly used chemotherapeutic drugs and their prognosis is relatively poor. But a new study has indicated why triple-negative breast cancer cell lines are sensitive to exposure to the chemotherapeutic cisplatin.
Similar news · Read more »
From clinical cancer research: rethinking therapeutic cancer vaccine trials
07-03-2007 · EurekAlert!
Ongoing therapeutic cancer vaccine trials have yet to show evidence of vaccines spurring a patient's immune system to shrink tumors -- yet patients who receive these vaccines in trials tend to live longer and respond better to subsequent treatment. In the July 1 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, a team of National Cancer Institute researchers asks a fundamental question: are we looking at cancer vaccine trials the wrong way?
Similar news · Read more »
Corals and climate change
08-22-2007 · EurekAlert!
A modest new lab at the Rosenstiel School is the first of its kind to tackle the global problem of climate change impacts on corals. Fully operational this month, this new lab has begun to study how corals respond to the combined stress of greenhouse warming and ocean acidification. The lab is the first to maintain corals under precisely controlled temperature and carbon dioxide conditions while exposing them to natural light conditions.
Similar news · Read more »
Experimental drug shows promise in advanced kidney cancer
09-26-2007 · EurekAlert!
A new drug has shown promise in patients with advanced kidney cancer whose options run out after their tumor fails to respond to the cutting edge therapy. The study, presented today at the European Cancer Conference in Barcelona, showed that the experimental drug, axitinib, shrank tumors and delayed progression of the disease in a group of patients who are among the toughest to treat.
Similar news · Read more »
Human safety, prosperity depend on better ocean observing system: Scientists
11-25-2007 · EurekAlert!
The Partnership for Observation of the Global Oceans says warming seas, over-fishing and pollution are among profound concerns that must be better measured to help society respond in a well-informed, timely and cost-effective way.
Similar news · Read more »
Diet and lifestyle critical to recovery, says study
01-17-2008 · EurekAlert!
Diet and lifestyle may play a much more significant role in a person's ability to respond favorably to certain drugs, including some cancer therapies, than previously understood, say scientists.
Similar news · Read more »
Making headway against hepatitis C: SLU study shows new drug combo effective in non-responders
10-30-2006 · EurekAlert!
Saint Louis University scientists are presenting research today on a more effective way to treat hepatitis C patients who have been unresponsive to current drug therapies.
Similar news · Read more »